Novo Nordisk confirms huge increase in sales despite supply constraints 0 08.08.2024 19:35 EurActiv Novo Nordisk is on track to make a significant contribution to Denmark's GDP through its obesity and diabetes treatments, despite supply constraints, according to the company's financial report for the first half of 2024. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
